Study design of the DAS-OLT trial: a randomized controlled trial to evaluate the impact of dexmedetomidine on early allograft dysfunction following liver transplantation

[1] D'Amico G(2006)Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies J Helatol 44 217-231

[2] Garcia-Tsao G(2012)Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR) J Hepatol 57 675-688

[3] Pagliaro L(2016)Liver transplantation in Australia and New Zealand Liver Transpl 22 830-838

[4] Adam R(2003)The utility of marginal donors in liver transplantation Liver Transpl 9 651-663

[5] Karam V(2015)Safely expanding the donor pool: brain dead donors with history of temporary cardiac arrest Liver Int 35 1756-1763

[6] Delvart V(1998)Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Transplantation 66 302-310

[7] O'Grady J(2010)Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors Liver Transpl 16 943-949

[8] Mirza D(2012)Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction Transplant Proc 44 1303-1306

[9] Klempnauer J(2014)Primary graft dysfunction after liver transplantation Hepatobiliary Pancreat Dis Int 13 125-137

[10] McCaughan GW(2016)Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements Ann Hepatol 15 53-60

[1] D'Amico G(2006)Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies J Helatol 44 217-231

[2] Garcia-Tsao G(2012)Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR) J Hepatol 57 675-688

[3] Pagliaro L(2016)Liver transplantation in Australia and New Zealand Liver Transpl 22 830-838

[4] Adam R(2003)The utility of marginal donors in liver transplantation Liver Transpl 9 651-663

[5] Karam V(2015)Safely expanding the donor pool: brain dead donors with history of temporary cardiac arrest Liver Int 35 1756-1763

[6] Delvart V(1998)Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Transplantation 66 302-310

[7] O'Grady J(2010)Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors Liver Transpl 16 943-949

[8] Mirza D(2012)Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction Transplant Proc 44 1303-1306

[9] Klempnauer J(2014)Primary graft dysfunction after liver transplantation Hepatobiliary Pancreat Dis Int 13 125-137

[10] McCaughan GW(2016)Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements Ann Hepatol 15 53-60